Five years ago, Milton Rubin created the Milton B. Rubin Family Endowed Chair as a means of expressing his gratitude for the ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Dr. Rainer Storb began studying bone marrow transplantation when the field was in its infancy. As he retires 60 years later, ...

Katie Monin, a Seattle lawyer and mother of two young children, chose proton therapy as part of her treatment for brain ...

It’s a very different world now in cancer,” said longtime patient advocate Ginny Mason. “Now you need to understand the ...

Armstrong, PhD, an assistant professor in the Herbold Computational Biology Program in Fred Hutch’s Public Health Sciences ...

Vinh Bui and Tram Le established an endowed chair at Fred Hutch to support lung cancer researcher Dr. David MacPherson ...

Join our first-ever Fred Hutch Giving Day September 17, 2025 as we celebrate 50 years of breakthroughs — in cancer, infectious disease and fundamental research.

Join us for our annual prostate cancer conference covering topics for patients and caregivers. Hosted by Fred Hutch Cancer Center, in conjunction with the OHSU Knight Cancer Institute, this event ...

Patient provider profile for Dr. Madhav Dhodapkar, hematologist and medical oncologist at Fred Hutch Cancer Center.

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

A Fred Hutch study involving postmenopausal, overweight and obese women who took 2,000 IUs of vitamin D daily for a year found that those whose vitamin D blood levels increased the most had the ...